NRX Pharmaceuticals OverviewNRX Pharmaceuticals EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NRXP.
Quarterly EBIT
-$4.74M
↑ 13.97% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$32.81M
↓ 33.03% YoY
Trailing 12 months ending Mar 31, 2026
NRX Pharmaceuticals OverviewEBIT (Earnings Before Interest and Taxes) analysis for NRXP.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026